Search Results

An Interview With Mark A. Turco, MD

Cardiac Interventions Today talks with one of today's leading interventional cardiologists about his recent work, the future of coronary interventions, and his personal experience as a principal investigator.

By Mark A. Turco, MD

How Has the DES Market Changed?

Mark A. Turco, MD, FACC, an interventional cardiologist turned chief medical officer, offers a unique perspective regarding the pressures currently facing the DES market.

Taxus Clinical Update

Experts discuss the current role of the Taxus stent.

By Mark A. Turco, MD, FSCAI, FACC, and Eberhard Grube, MD, FSCAI, FACC

DESs in Multivessel Disease

Lessons learned from large registry experience.

By Daniel W. Carlson, MD, and Mark A. Turco, MD, FACC, FSCAI

The DES Landscape in 2011

Future directions in drug-eluting stent design.

By Jeffrey S. Kunz, MD, and Mark A. Turco, MD, FACC, FSCAI

Reducing Door-to-Balloon Times With Medical Simulation

Medical simulation is well suited to educate care teams in reducing door-to-balloon times.

By Mark A. Turco, MD, FSCAI, FACC, and Amy L. Ketron, RN, BSN

Coronary Artery Bifurcation Disease

Treating native coronary artery bifurcation stenoses with the Devax Axxess dedicated bifurcation stent.

By John A. Ormiston, MBChB, FRACP, FCSANZ, and Mark A. Turco, MD, FACC, FSCAI

Multivessel Interventions

By Ted E. Feldman, MD, Chief Medical Editor

Chief Medical Editor's Page

Optimal PCI in Contemporary Practice

By Ted E. Feldman, MD, FSCAI, Chief Medical Editor

Left Main and Bifurcation Disease

By Ted E. Feldman, MD, Chief Medical Editor

2008 Drug-Eluting Stent Update

By Ted E. Feldman, MD, FSCAI, Chief Medical Editor

Chief Medical Editor's Page: DES Evolution

By Ted E. Feldman, MD, FSCAI

Lesion Assessment

By Ted E. Feldman, MD, FSCAI, Chief Medical Editor

Ultrasound-Guided Radial Artery Access

A step-by-step guide to using US in the cath lab.

By Jonathan S. Roberts, MD, FACC, FSCAI, and Rashmi Manur, MBBS, MPH

Drug-Eluting Stents for Off-Label Indications

A review of studies comparing DES to BMS for on- and off-label uses.

By Sameer J. Khandhar, MD; Suresh R. Mulukutla, MD, FACC, FSCAI; and Oscar C. Marroquin, MD, FACC, FSCAI